Ha habido 50 transacciones internas recientes registradas para Alpine Immune Sciences, Inc. (ALPN), incluyendo 13 compras y 37 ventas. El total de compras internas fue valorado en $2.7M y el total de ventas internas en $559.86M.
Internos destacados con actividad reciente incluyen Conway Robert E, Gold Mitchell, Topper James N. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — ALPN
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-05-20 |
Conway Robert E |
Director |
Devolución de Acciones |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Gold Mitchell |
Executive Chairman and CEO |
Devolución de Acciones |
240,000 |
$18.33 |
$4.4M |
- |
| 2024-05-20 |
Topper James N |
Director |
Devolución de Acciones |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Thompson Peter A. |
Director |
Devolución de Acciones |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Cui Xiangmin |
10 Percent Owner |
Devolución de Acciones |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Rickey James Paul |
See Remarks |
Devolución de Acciones |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Peetz Christopher |
Director |
Devolución de Acciones |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Peng Stanford L |
See Remarks |
Devolución de Acciones |
120,000 |
$18.33 |
$2.2M |
- |
| 2024-05-20 |
Hernday Natasha |
Director |
Devolución de Acciones |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Drappa Jorn |
Director |
Devolución de Acciones |
17,500 |
$19.00 |
$332.5K |
- |
| 2024-05-20 |
Durand Remy |
Chief Business Officer |
Devolución de Acciones |
78,000 |
$18.33 |
$1.43M |
- |
| 2024-05-20 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
Devolución de Acciones |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-05-18 |
Orbimed Advisors Llc |
Director |
OPA (Venta) |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Gold Mitchell |
Executive Chairman and CEO |
OPA (Venta) |
2,627,157 |
$65.00 |
$170.77M |
- |
| 2024-05-18 |
Topper James N |
Director |
OPA (Venta) |
2,829,347 |
$65.00 |
$183.91M |
- |
| 2024-05-18 |
Thompson Peter A. |
Director |
OPA (Venta) |
264,315 |
$65.00 |
$17.18M |
- |
| 2024-05-18 |
Cui Xiangmin |
10 Percent Owner |
OPA (Venta) |
1,735,544 |
$65.00 |
$112.81M |
- |
| 2024-05-08 |
Gold Mitchell |
Executive Chairman and CEO |
Ejercicio de Opciones |
13,245 |
$7.55 |
$100K |
109,245 |
| 2024-05-08 |
Peng Stanford L |
See Remarks |
Ejercicio de Opciones (Venta) |
161,492 |
$0.65 |
$104.97K |
- |
| 2024-05-08 |
Durand Remy |
Chief Business Officer |
Ejercicio de Opciones (Venta) |
10,000 |
$4.76 |
$47.6K |
- |
| 2024-05-08 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
Ejercicio de Opciones |
22,820 |
$12.07 |
$275.44K |
30,120 |
| 2024-05-07 |
Rickey James Paul |
See Remarks |
Ejercicio de Opciones (Venta) |
398 |
$5.02 |
$2K |
137 |
| 2024-04-25 |
Topper James N |
Director |
Ejercicio de Opciones (ITM) |
1,200,000 |
$0.00 |
$1.2K |
- |
| 2024-04-03 |
Fuhs Ulrich Martin |
Chief Accounting Officer |
Disposición |
14,600 |
$35.89 |
$523.99K |
- |
| 2024-01-26 |
Rickey James Paul |
See Remarks |
Venta Informativa |
73,764 |
$22.31 |
$1.65M |
- |
| 2024-01-25 |
Rickey James Paul |
See Remarks |
Venta Informativa |
236 |
$22.00 |
$5.19K |
- |
| 2024-01-18 |
Cui Xiangmin |
10 Percent Owner |
Ejercicio de Opciones (ITM) |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-18 |
Decheng Capital China Life Sciences Usd Fund Iii, L.p. |
10 Percent Owner |
Ejercicio de Opciones (ITM) |
1,234,636 |
$12.74 |
$15.73M |
- |
| 2024-01-11 |
Orbimed Advisors Llc |
Director |
Ejercicio de Opciones (ITM) |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-11 |
Thompson Peter A. |
Director |
Ejercicio de Opciones (ITM) |
145,251 |
$12.74 |
$1.85M |
- |
| 2024-01-04 |
Gold Mitchell |
Executive Chairman and CEO |
Concesión de RSU |
96,000 |
- |
- |
96,000 |
| 2024-01-04 |
Rickey James Paul |
See Remarks |
Concesión de RSU |
31,200 |
- |
- |
31,200 |
| 2024-01-04 |
Peng Stanford L |
See Remarks |
Concesión de RSU |
48,000 |
- |
- |
72,371 |
| 2024-01-04 |
Durand Remy |
Chief Business Officer |
Concesión de RSU |
31,200 |
- |
- |
38,104 |
| 2024-01-02 |
Conway Robert E |
Director |
Concesión de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Topper James N |
Director |
Concesión de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Thompson Peter A. |
Director |
Concesión de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Cui Xiangmin |
10 Percent Owner |
Concesión de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Peetz Christopher |
Director |
Concesión de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Hernday Natasha |
Director |
Concesión de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2024-01-02 |
Drappa Jorn |
Director |
Concesión de RSU |
17,500 |
$19.00 |
$332.5K |
17,500 |
| 2023-12-28 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-28 |
Gold Mitchell |
Executive Chairman and CEO |
Ejercicio de Opciones (Venta) |
74,441 |
$12.74 |
$948.38K |
- |
| 2023-12-28 |
Thompson Peter A. |
Director |
Venta Informativa |
139,166 |
$18.32 |
$2.55M |
264,315 |
| 2023-12-27 |
Gold Mitchell |
Executive Chairman and CEO |
Venta Informativa |
29,573 |
$20.04 |
$592.72K |
- |
| 2023-12-27 |
Orbimed Advisors Llc |
Director |
Venta Informativa |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-27 |
Thompson Peter A. |
Director |
Venta Informativa |
18,922 |
$19.96 |
$377.68K |
406,609 |
| 2023-12-26 |
Gold Mitchell |
Executive Chairman and CEO |
Ejercicio de Opciones (Venta) |
2,402 |
$0.45 |
$1.08K |
- |
| 2023-12-22 |
Gold Mitchell |
Executive Chairman and CEO |
Venta Informativa |
37,825 |
$20.43 |
$772.59K |
- |
| 2023-12-19 |
Gold Mitchell |
Executive Chairman and CEO |
Venta Informativa |
2,402 |
$20.01 |
$48.06K |
- |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
